Akut Böbrek Hasarı Biyobelirteçleri
Özet
Referanslar
Singh R, Dodkins J, Doyle JF, et al. Acute Kidney Injury Biomarkers: What Do They Tell Us? Contrib Nephrol 2018;193:21-34.
Konukoglu D. Biomarkers for acute kidney injury. Int J Med Biochem 2018;1(2):80-7.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2(6):131-8.
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204‐R212.
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31.
Rizvi MS, Kashani KB. Biomarkers for Early Detection of Acute Kidney Injury. J App Lab Med 2017;2(3): 386-99.
Teo SH, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol 2017;31(3):331‐44.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69 (3):89-95.
Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol 2015;10(1):147-55.
Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019;394(10212):1949‐64.
Schinstock CA, Semret MH, Wagner SJ, et al. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol Dial Transplant 2013;28(5):1175-85.
Vijayan A, Faubel S, Askenazi DJ, et al. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis 2016;68(1):19-28.
Darmon M, Truche AS, Abdel-Nabey M, et al. Early Recognition of Persistent Acute Kidney Injury. Semin Nephrol 2019;39(5):431-41.
Referanslar
Singh R, Dodkins J, Doyle JF, et al. Acute Kidney Injury Biomarkers: What Do They Tell Us? Contrib Nephrol 2018;193:21-34.
Konukoglu D. Biomarkers for acute kidney injury. Int J Med Biochem 2018;1(2):80-7.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2(6):131-8.
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204‐R212.
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31.
Rizvi MS, Kashani KB. Biomarkers for Early Detection of Acute Kidney Injury. J App Lab Med 2017;2(3): 386-99.
Teo SH, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol 2017;31(3):331‐44.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69 (3):89-95.
Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol 2015;10(1):147-55.
Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019;394(10212):1949‐64.
Schinstock CA, Semret MH, Wagner SJ, et al. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury. Nephrol Dial Transplant 2013;28(5):1175-85.
Vijayan A, Faubel S, Askenazi DJ, et al. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis 2016;68(1):19-28.
Darmon M, Truche AS, Abdel-Nabey M, et al. Early Recognition of Persistent Acute Kidney Injury. Semin Nephrol 2019;39(5):431-41.
